RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can stem cell dose boost recovery in tough lymphoma?
Disease control OngoingThis study looks at whether the number of stem cells given during a transplant affects how well the immune system recovers in people with relapsed or refractory diffuse large B-cell lymphoma. About 59 adults who have already tried one chemotherapy will receive high-dose therapy f…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Real-world study tests epcoritamab for hard-to-treat lymphoma
Disease control OngoingThis study tracks 150 adults with relapsed or refractory diffuse large B-cell lymphoma who have already tried at least two other treatments. Researchers want to see how well epcoritamab works outside of a controlled clinical trial, focusing on tumor shrinkage and side effects. Th…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC